The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Blin Emmanuel since 2015.
The trader's CIK number is 1642115.
At the time of the last reporting, Blin Emmanuel was the SVP, Head of Commercialization of Bristol Myers Squibb Co. (stock ticker symbol BMY).
Also see all insider trading activities at Bristol Myers Squibb Co.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | BMY | 0 | $0 | 0 | $0 | 13,275 | $0 |
| 2016 | BMY | 0 | $0 | 0 | $0 | 13,477 | $0 |
| 2015 | BMY | 0 | $0 | 0 | $0 | 951 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-03-10 | BMY | Option Ex | 13,275 | .00 | 0 |
| 2016-07-02 | BMY | Option Ex | 951 | .00 | 0 |
| 2016-03-10 | BMY | Option Ex | 11,707 | .00 | 0 |
| 2016-03-06 | BMY | Option Ex | 819 | .00 | 0 |
| 2015-07-02 | BMY | Option Ex | 951 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Blin Emmanuel (SVP, Head of Commercialization of Bristol Myers Squibb Co at the time of this reporting) see the Securities and Exchange Commission (SEC) website.